login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
LEXARIA BIOSCIENCE CORP (LEXX) Stock News
USA
- NASDAQ:LEXX -
US52886N4060
-
Common Stock
0.8326
USD
+0.01 (+0.95%)
Last: 10/17/2025, 8:25:15 PM
0.8649
USD
+0.03 (+3.88%)
After Hours:
10/17/2025, 8:25:15 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LEXX Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: ACCESS Newswire
Lexaria Bioscience Corp. Provides Strategic Update
17 days ago - By: Benzinga
- Mentions:
BOLT
SCLX
TSHA
RVPH
...
12 Health Care Stocks Moving In Thursday's Intraday Session
20 days ago - By: ACCESS Newswire
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
23 days ago - By: Benzinga
- Mentions:
MRM
KUKE
CPOP
BIAF
...
Nasdaq Gains 100 Points; US Consumer Sentiment Falls
a month ago - By: ACCESS Newswire
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
2 months ago - By: ACCESS Newswire
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
3 months ago - By: ACCESS Newswire
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
3 months ago - By: ACCESS Newswire
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
4 months ago - By: ACCESS Newswire
Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
5 months ago - By: ACCESS Newswire
Lexaria Attending BIO International Convention
24 days ago - By: ACCESS Newswire
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2 months ago - By: ACCESS Newswire
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
6 months ago - By: ACCESS Newswire
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology
7 months ago - By: ACCESS Newswire
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
7 months ago - By: ACCESS Newswire
Lexaria's Human GLP-1 Study #5 Begins Dosing
8 months ago - By: ACCESS Newswire
The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience
2 months ago - By: ACCESS Newswire
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
4 months ago - By: ACCESS Newswire
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
5 months ago - By: ACCESS Newswire
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
6 months ago - By: ACCESS Newswire
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
8 months ago - By: ACCESS Newswire
Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm
6 months ago - By: ACCESS Newswire
Lexaria Announces $2 Million Registered Direct Offering of Common Stock
7 months ago - By: ACCESS Newswire
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
Please enable JavaScript to continue using this application.